Video

Initial Results of the Ongoing MYSTIC Trial in Stage IV Lung Cancer

Author(s):

David R. Gandara, MD

David R. Gandara, MD, professor of Medicine, University of California Davis Comprehensive Cancer Center, discusses the initial results of the ongoing MYSTIC trial, which is exploring the combination of durvalumab (Imfinzi) and tremelimumab versus chemotherapy in stage IV lung cancer.

David R. Gandara, MD, professor of Medicine, University of California Davis Comprehensive Cancer Center, discusses the initial results of the ongoing MYSTIC trial, which is exploring the combination of durvalumab (Imfinzi) and tremelimumab versus chemotherapy in stage IV lung cancer.

Related Videos
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
Davide Matino, MD, MSc: Bringing Marstacimab Treatment to Hemophilia A and B
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Highlighting the Danger of SCI Progression during iTTP Remission, with Shruti Chaturvedi, MBSS, MS
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Related Content
2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Jacob Sands, MD
December 9th 2024

2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Jacob Sands, MD

Tim Smith
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Oussama Wazni, MD | Credit: HCPLive
November 17th 2024

Oussama Wazni, MD, MBA: OPTION Trial and the Role of LAAC in Atrial Fibrillation

Oussama Wazni, MD Patrick Campbell
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
April 17th 2024

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Discussing Unmet Needs for Skin Cancer with Laura K. Ferris, MD, PhD, and Neal Bhatia, MD
October 28th 2024

Discussing Unmet Needs for Skin Cancer with Laura K. Ferris, MD, PhD, and Neal Bhatia, MD

Tim Smith
Jonathan Barratt, PhD | Credit: IgA Nephropathy Foundation
October 27th 2024

ORIGIN OLE Data Solidify Atacicept Disease-Modifying Potential for IgA Nephropathy

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.